What Hanger, Inc. Does

Founded in 1861, Hanger, Inc. is a leading provider of orthotic and prosthetic (O&P) patient care services and products. Operating a national network of over 800 clinics, the company specializes in the custom design, fabrication, and fitting of prosthetic limbs, braces, and other supportive devices. Hanger integrates clinical care with in-house manufacturing, creating personalized solutions that restore mobility and independence for patients. With 5,001-10,000 employees, it is a large-scale enterprise in the healthcare and medical device manufacturing space, managing a complex workflow from clinical evaluation to device delivery and ongoing patient support.

Why AI Matters at This Scale

For a company of Hanger's size and vintage, operational efficiency and personalized care at scale are paramount. The traditional O&P process is labor-intensive, relying heavily on clinician expertise and manual craftsmanship for each custom device. This creates bottlenecks, variable outcomes, and high costs. AI presents a transformative lever to systematize excellence, harnessing the vast clinical dataset accumulated over decades to predict outcomes, automate design, and optimize the entire patient journey. At this scale, even marginal improvements in fitting speed, device performance, or inventory turnover translate into millions in savings and significantly enhanced patient satisfaction across the national network.

Concrete AI Opportunities with ROI Framing

1. Generative Design for Prosthetic Sockets (High Impact)

Implementing AI-driven generative design software can automate the initial modeling of prosthetic sockets from patient scans. This reduces manual sculpting and digital design time from hours to minutes. The ROI is direct: a 30% reduction in technician labor per device, faster patient delivery, and potentially better-fitting sockets through algorithmic optimization, leading to fewer adjustment appointments and higher patient retention.

2. Predictive Analytics for Patient Outcomes (Medium Impact)

Machine learning models can analyze historical fitting data, patient demographics, and device types to predict which patients might experience discomfort or require revisions. This enables proactive intervention. The ROI manifests as reduced costly return visits, improved patient outcomes (a key quality metric), and more efficient scheduling of clinical resources, protecting revenue and enhancing care quality.

3. Intelligent Supply Chain Management (Medium Impact)

AI can forecast demand for thousands of components across all clinics by analyzing seasonal trends, regional patient demographics, and device types. This optimizes inventory levels, reduces capital tied up in stock, and minimizes emergency shipping costs. For a large distributed manufacturer, this can yield 15-20% reductions in inventory costs and near-elimination of production delays due to part shortages.

Deployment Risks Specific to This Size Band

Deploying AI in a large, established organization like Hanger carries specific risks. First, integration complexity: legacy Electronic Health Record (EHR) and manufacturing systems may be siloed, requiring significant middleware or API development to create a unified data lake for AI training. Second, change management: rolling out new AI tools to thousands of clinicians and technicians across hundreds of locations requires extensive training and can face resistance to altered workflows. Third, regulatory scrutiny: any AI tool influencing device design or patient care could be subject to FDA regulation as Software as a Medical Device (SaMD), necessitating a rigorous and costly validation process. A successful strategy must involve phased pilots, close collaboration with clinical staff, and early engagement with regulatory affairs to navigate these hurdles.